Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alembic Pharmaceuticals Ltd.

www.alembic-india.com

Latest From Alembic Pharmaceuticals Ltd.

Alembic Builds US Launch Pipeline As It Looks To Oncology Arena

Alembic is building up an extensive roster of solid-dose, ophthalmic and dermatological drugs to introduce in the US. With facility clearance from the FDA, the Indian firm can now target the US market for oral solids to treat cancer.

Business Strategies Cancer

Lyrica Generics Launch, But Pfizer Has Been Bracing For The Hit

The first generic versions of Pfizer's blockbuster pain medicine pregabalin have launched in the US. Pfizer has guided investors the company will return to growth in 2020 after cycling through the loss.

Generic Drugs Launches

Cipla Docks Into China With Manufacturing Plans In Tow

More Indian companies are headed to China, with Cipla the latest to seal a joint venture there, though the firm has previous links with the country. Respiratory products will lead Cipla’s line-up in China, a market seen as a crucial cog in the firm’s future road map.

China Commercial

Cipla Docks Into China, Manufacturing Plans In Tow

More Indian companies are headed to China, with Cipla the latest to seal a joint venture there, though the firm has previous links with the country. Respiratory products will lead Cipla’s line-up in China, a market seen as a crucial cog in the firm’s future road map.

China Commercial
See All

Company Information

  • Industry
  • Distributors
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Pulmonary
      • Transdermal
    • Generic Drugs
    • Nutraceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Alembic Pharmaceuticals Ltd.
  • Senior Management
  • Chirayu R Amin, Chmn. & Managing Dir.
    Pranav Amin, Pres., International Bus.
  • Contact Info
  • Alembic Pharmaceuticals Ltd.
    Phone: (91) 265 228 0550
    Alembic Rd.
    Vadodara
    Gujarat, 390 003
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register